The release of the CMS-1832-F Final Rule (CY 2026 Medicare Physician Fee Schedule) has fundamentally altered the economics of cellular and tissue-based products (CTPs). The industry is now facing the “Skin Substitute Cliff,” where the traditional ASP + 6% model has been obliterated and replaced with a flat-rate payment of $127.28 per cm² for the […]
Why is the CMS-1832-F Final Rule a “Death Sentence” for Unprepared Wound Care Practices?









